Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-05-17 @ 6:16 PM
Study NCT ID:
NCT00790127
Status:
COMPLETED
Last Update Posted:
2011-05-20
First Post:
2008-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia
Sponsor:
HemaQuest Pharmaceuticals Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HQP-2008-003b
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Susan Perrine, M.D. Chief Scientific Officer, VP Clinical Affairs
Old Organization:
HemaQuest Pharmaceuticals Inc.